Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats

Fig. 5

Effects of sorafenib and/or GdCl3 on interactions of HSCs, KCs and SECs in DMN-induced liver fibrosis in rats. Hepatic cryosections were stained with antibodies against α-SMA (blue), CD68 (red), and vWF (green) (magnification X400, n = 3). 4 W, DMN for 4 weeks; S, DMN for 4 weeks plus sorafenib for 2 weeks; G, DMN for 4 weeks plus GdCl3 for 2 weeks; S + G, DMN for 4 weeks plus sorafenib and GdCl3 for 2 weeks

Back to article page